Evidence map›Paper›PMID 22841997›Full record

ArticleBrain, behavior, and immunity2012

Beta adrenergic blockade decreases the immunomodulatory effects of social disruption stress.

M L Hanke, N D Powell, L M Stiner, M T Bailey, J F Sheridan

Registry-linked trialAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06263452 (Beta-Blocker Influences on Inflammatory and Neural Responses to Stress), which is not on this map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06263452 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2024 to 2026Enrolled120ConditionsCardiovascular DiseaseArmsPropranolol, Placebo
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Animal Inflammation-Based Models of Neuropsychiatric Disorders.Advances in experimental medicine and biology · 2023
    Article
  13. Review
  14. Microglia as Central Protagonists in the Chronic Stress Response.Neurology(R) neuroimmunology & neuroinflammation · 2022
    Review
  15. Effect of chronic stress on tumorigenesis and development.Cellular and molecular life sciences : CMLS · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

M L HankeDivision of Oral Biology, The Ohio State University College of Dentistry, Columbus, OH 43210, USA.
N D Powell
L M Stiner
M T Bailey
J F Sheridan
The Ohio State University · USInstitute for Behavioral Medicine · US

Funding

Comprehensive Training in Oral &Craniofacial SciencesT32DE014320 · NIDCR · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2001 to 2022
$10.2M
STRESS-INDUCED IMMUNOSUPPRESSION OF ANTIVIRAL IMMUNITYR01MH046801 · NIMH · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 1991 to 2008
$2.7M
Social threat primes myeloid progenitor cells and microglia: role in anxietyR01MH093473 · NIMH · OHIO STATE UNIVERSITY · PI SHERIDAN, JOHN F · 2012 to 2016
$1.9M
NIDCR NIH HHS T32 DE014320NIDCR NIH HHS T32DE014320NIMH NIH HHS R01 MH046801NIMH NIH HHS R01MH046801NIMH NIH HHS R01 MH093473
6 · The paper itself

Abstract

During physiological or psychological stress, catecholamines produced by the sympathetic nervous system (SNS) regulate the immune system. Previous studies report that the activation of β-adrenergic receptors (βARs) mediates the actions of catecholamines and increases pro-inflammatory cytokine production in a number of different cell types. The impact of the SNS on the immune modulation of social defeat has not been examined. The following studies were designed to determine whether SNS activation during social disruption stress (SDR) influences anxiety-like behavior as well as the activation, priming, and glucocorticoid resistance of splenocytes after social stress. CD-1 mice were exposed to one, three, or six cycles of SDR and HPLC analysis of the plasma and spleen revealed an increase in catecholamines. After six cycles of SDR the open field test was used to measure behaviors characteristic of anxiety and indicated that the social defeat induced increase in anxiety-like behavior was blocked by pre-treatment with the β-adrenergic antagonist propranolol. Pre-treatment with the β-adrenergic antagonist propranolol did not significantly alter corticosterone levels indicating no difference in activation of the hypothalamic-pituitary-adrenal axis. In addition to anxiety-like behavior the SDR induced splenomegaly and increase in plasma IL-6, TNFα, and MCP-1 were each reversed by pre-treatment with propranolol. Furthermore, flow cytometric analysis of cells from propranolol pretreated mice reduced the SDR-induced increase in the percentage of CD11b(+) splenic macrophages and significantly decreased the expression of TLR2, TLR4, and CD86 on the surface of these cells. In addition, supernatants from 18h LPS-stimulated ex vivo cultures of splenocytes from propranolol-treated SDR mice contained less IL-6. Likewise propranolol pre-treatment abrogated the glucocorticoid insensitivity of CD11b(+) cells ex vivo when compared to splenocytes from SDR vehicle-treated mice. Together, this study demonstrates that the immune activation and priming effects of SDR result, in part, as a consequence of SNS activation.

Indexed as

Social EnvironmentAdrenergic beta-AntagonistsAnimalsAnxietyB7-2 AntigenCatecholaminesCD11b AntigenCell ProliferationCell SurvivalCorticosteroneFlow CytometryGlucocorticoidsHypothalamo-Hypophyseal SystemInterleukinsLipopolysaccharidesPituitary-Adrenal SystemAdrenergic beta-AntagonistsB7-2 AntigenCatecholaminesCD11b AntigenCorticosteroneGlucocorticoidsInterleukinsLipopolysaccharidesPropranololTlr2 protein, ratTlr4 protein, ratToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID22841997
PMCPMC3506115
OpenAlexW1975493402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.